Work

A phase I pilot study of personalized neoantigen peptide-based vaccine in combination with pembrolizumab in advanced solid tumors (PNeoVCA).

Year: 2024

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2024.42.16_suppl.tps2700

Authors: Yanyan Lou, Saranya Chumsri, Yan W. Asmann, Qian Shi, Jordan Reynolds, Brian Necela, Nadine Norton, Michael Gustafson, Winston Tan, Rami Manochakian, Yujie Zhao, Hani M. Babiker, Trevanne Rose Matthews Hew, Keith L. Knutson

Institutions: Mayo Clinic in Florida, Mayo Clinic, Mayo Clinic in Arizona

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Mayo Clinic

OpenAlex ID: W4400265232

Cites:

Cited by: 6

Related to: 10